Biofire molecular testing
Ended Awarded Last action
- Contract number
- 36C24425N0026
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $161,548
Award facts
- Contract value 20% obligated
- $790,253.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA 17042, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$114,262 | |
| Funding Only Action | -$6,799 | |
| Funding Only Action | $26,638 | |
| Funding Only Action | $46,402 | |
| Original award | $209,569 |
About this award
Biomerieux Inc., doing business as Vitek Systems, Inc., has been awarded a $790,253.98 firm fixed-price BPA call by Veterans Integrated Service Network (VISN) 4 for biofire molecular testing solutions. The contract, effective October 1, 2024, with a completion date of September 30, 2025, will be performed in Lebanon, Pennsylvania. This award is issued under the GSA Federal Supply Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII) and does not utilize a set-aside designation, reflecting Biomerieux's position as a specialized provider of advanced diagnostic technologies to the Department of Veterans Affairs. The BioFire platform represents a molecular pathogen detection system widely utilized across VA healthcare networks for rapid infectious disease identification.
This contract represents a call under Biomerieux's existing Blanket Purchase Agreement vehicle with VISN 4, enabling the Veterans Integrated Service Network to access the company's specialized diagnostic capabilities on an as-needed basis. Biomerieux maintains an extensive portfolio of federal diagnostic contracts across multiple VISNs and government healthcare agencies, providing critical laboratory equipment, reagents, and testing systems to support clinical operations. The contract supports VISN 4's ability to deliver advanced diagnostic services to veterans' medical facilities throughout its service network, enhancing clinical laboratory capabilities for infectious disease detection and response.
Quick answers
Who was awarded contract 36C24425N0026?
36C24425N0026 was awarded to Biomerieux Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24425N0026 worth?
The government has obligated $161,548 on 36C24425N0026. Its current value, with exercised options, is $790,254.
Is contract 36C24425N0026 an order under another contract?
Yes. 36C24425N0026 is a BPA call under 36F79724D0020-36C24425A0002, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24425N0026 competed?
The extent of competition for 36C24425N0026 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award